Funded Startups in Centennial
Centennial’s most recent funded entries show a wide spread in disclosed round sizes, with Boom Supersonic’s $300M (Series B, 2025-12-09) standing out far a…
Centennial’s most recent funded entries show a wide spread in disclosed round sizes, with Boom Supersonic’s $300M (Series B, 2025-12-09) standing out far above the rest of the disclosed amounts. The next-largest disclosed round is BillingPlatform’s $90M (2024-01-24), while NUBURU’s $65M (2024-10-07) and NovoHydrogen’s $24M (2023-09-25) sit well below, and two other rows are undisclosed (Axis Medical 2026-02-19; Western Microsurgical 2025-02-03; SnoBahn 2024-06-24).
On timing, the 8 rows span 2023-09-25 through 2026-02-19, with a noticeable concentration between 2024-10-07 and 2025-12-09 where four of the eight entries appear (NUBURU 2024-10-07; MySimplePetLab 2024-11-26; Boom Supersonic 2025-12-09; Western Microsurgical 2025-02-03). Sector coverage is fragmented, with no sector repeating in three or more entries, and “Series Unknown” (5 of 8 rows) plus “undisclosed” amounts (3 of 8 rows) forming a large share of the dataset.
Most recent rounds
8 shownRelated listings
Frequently asked
What’s the largest disclosed round in Centennial on this page, and how does it compare to the other disclosed amounts?
Boom Supersonic’s disclosed $300M (Series B, 2025-12-09) is an outlier relative to the rest of the disclosed rounds: BillingPlatform’s $90M (2024-01-24) is the next-largest, followed by NUBURU’s $65M (2024-10-07) and NovoHydrogen’s $24M (2023-09-25). Three additional entries are undisclosed (Axis Medical 2026-02-19; Western Microsurgical 2025-02-03; SnoBahn 2024-06-24).
Are there temporal clusters in the Centennial deals shown here?
Yes. Four of the eight rows fall between 2024-10-07 and 2025-12-09: NUBURU (2024-10-07), MySimplePetLab (2024-11-26), Western Microsurgical (2025-02-03), and Boom Supersonic (2025-12-09). The earliest date shown is NovoHydrogen’s 2023-09-25, extending the full window to 2026-02-19 (Axis Medical).
Which stage labels dominate this subset, and what does that imply for comparability of deal size?
“Series Unknown” appears in 5 of 8 rows, and only one row is explicitly labeled Series B (Boom Supersonic, $300M on 2025-12-09). With 3 of 8 amounts marked undisclosed, disclosed comparisons are primarily among four labeled monetary figures ($24M, $65M, $90M, $100K, $300M), while three entries provide no amount (Axis Medical, Western Microsurgical, SnoBahn).
Which sectors are over-represented, and are there any 3+ entry repeats?
No sector repeats in three or more entries across the 8 rows; sectors are distributed across Biotechnology (Axis Medical), Manufacturing (Boom Supersonic), Commerce and Shopping (Western Microsurgical), Community and Lifestyle (MySimplePetLab), Energy (NUBURU), Sports (SnoBahn), Financial Services (BillingPlatform), and Administrative Services (NovoHydrogen).
Are there outliers worth prioritizing for outreach or due diligence beyond the $300M round?
Two additional size outliers sit at the high-middle and low end of disclosed amounts. BillingPlatform’s $90M (Financial Services, 2024-01-24) is the only other large disclosed figure, while MySimplePetLab’s $100K (Community and Lifestyle, 2024-11-26) is the smallest disclosed amount on the page compared with NUBURU’s $65M (2024-10-07) and NovoHydrogen’s $24M (2023-09-25).
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.